Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Chlorgyline
2. Clorgilin
3. Clorgyline
1. Clorgyline
2. 17780-72-2
3. Chlorgyline
4. Clorgilinum
5. Clorgilina
6. M And B 9302
7. Clorgiline [inn]
8. M & B 9302
9. N-methyl-n-propargyl-3-(2,4-dichlorophenoxy)propylamine
10. N-(3-(2,4-dichlorophenoxy)propyl)-n-methyl-2-propynylamine
11. M&b 9302
12. Clorgiline (inn)
13. Lyj16fzu9q
14. N-(3-(2,4-dichlorophenoxy)propyl)-n-methylprop-2-yn-1-amine
15. Chembl8706
16. Chebi:3763
17. N-[3-(2,4-dichlorophenoxy)propyl]-n-methylprop-2-yn-1-amine
18. 2-propyn-1-amine, N-(3-(2,4-dichlorophenoxy)propyl)-n-methyl-
19. 2-propynylamine, N-(3-(2,4-dichlorophenoxy)propyl)-n-methyl-
20. Clorgilinum [inn-latin]
21. Clorgilina [inn-spanish]
22. 2-propyn-1-amine, N-(3-(2,4-dichlorophenoxy)propyl)-n-methyl- (9ci)
23. Unii-lyj16fzu9q
24. Cas-17780-75-5
25. Brn 1976758
26. 2-propyn-1-amine, N-[3-(2,4-dichlorophenoxy)propyl]-n-methyl-, Hydrochloride
27. 3-(2,4-dichlorophenoxy)-n-methyl-n-prop-2-ynylpropan-1-amine
28. Clorgiline [inn:ban]
29. Prestwick0_000344
30. Prestwick1_000344
31. Prestwick2_000344
32. Prestwick3_000344
33. Lopac-m-3778
34. Lopac0_000746
35. Schembl61914
36. Bspbio_000407
37. Us8633208, Clorgyline
38. Spbio_002328
39. Bpbio1_000449
40. Gtpl6636
41. Dtxsid3048445
42. Bdbm15581
43. Zinc22200090
44. Ccg-204831
45. Db04017
46. Sdccgsbi-0050724.p003
47. Ncgc00015669-01
48. Ncgc00015669-02
49. Ncgc00015669-03
50. Ncgc00015669-04
51. Ncgc00015669-11
52. Ncgc00162235-01
53. M&b-9302
54. Sbi-0050724.p002
55. A20772
56. D03248
57. L001342
58. Q2889652
59. Brd-k73251053-003-03-2
60. Brd-k73251053-003-13-1
61. [3-(2,4-dichloro-phenoxy)-propyl]-methyl-prop-2-ynyl-amine
62. [3-(2,4-dichlorophenoxy)propyl](methyl)prop-2-yn-1-ylamine
63. N-[3-(2,4-dichlorophenoxy)propyl]-n-methyl-prop-2-yn-1-amine
64. 3-(2,4-dichlorophenoxy)-n-methyl-n-prop-2-ynyl-propan-1-amine
65. N-[(2,6-dichloro-4-methyl-3-pyridyl)carbonyl]-n-(3,4-dichlorophenyl)urea
66. Clg
| Molecular Weight | 272.17 g/mol |
|---|---|
| Molecular Formula | C13H15Cl2NO |
| XLogP3 | 4.2 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 6 |
| Exact Mass | 271.0530695 g/mol |
| Monoisotopic Mass | 271.0530695 g/mol |
| Topological Polar Surface Area | 12.5 Ų |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Complexity | 263 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antidepressive Agents
Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)
Monoamine Oxidase Inhibitors
A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) (See all compounds classified as Monoamine Oxidase Inhibitors.)
ABOUT THIS PAGE
29
PharmaCompass offers a list of Clorgyline API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Clorgyline manufacturer or Clorgyline supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clorgyline manufacturer or Clorgyline supplier.
PharmaCompass also assists you with knowing the Clorgyline API Price utilized in the formulation of products. Clorgyline API Price is not always fixed or binding as the Clorgyline Price is obtained through a variety of data sources. The Clorgyline Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Clorgilina manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clorgilina, including repackagers and relabelers. The FDA regulates Clorgilina manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clorgilina API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Clorgilina supplier is an individual or a company that provides Clorgilina active pharmaceutical ingredient (API) or Clorgilina finished formulations upon request. The Clorgilina suppliers may include Clorgilina API manufacturers, exporters, distributors and traders.
click here to find a list of Clorgilina suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Clorgilina DMF (Drug Master File) is a document detailing the whole manufacturing process of Clorgilina active pharmaceutical ingredient (API) in detail. Different forms of Clorgilina DMFs exist exist since differing nations have different regulations, such as Clorgilina USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Clorgilina DMF submitted to regulatory agencies in the US is known as a USDMF. Clorgilina USDMF includes data on Clorgilina's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Clorgilina USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Clorgilina suppliers with USDMF on PharmaCompass.
Clorgilina Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Clorgilina GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Clorgilina GMP manufacturer or Clorgilina GMP API supplier for your needs.
A Clorgilina CoA (Certificate of Analysis) is a formal document that attests to Clorgilina's compliance with Clorgilina specifications and serves as a tool for batch-level quality control.
Clorgilina CoA mostly includes findings from lab analyses of a specific batch. For each Clorgilina CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Clorgilina may be tested according to a variety of international standards, such as European Pharmacopoeia (Clorgilina EP), Clorgilina JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Clorgilina USP).
